Search

John A. Ward

Examiner (ID: 10393)

Most Active Art Unit
2875
Art Unit(s)
2885, 2875
Total Applications
1293
Issued Applications
1015
Pending Applications
41
Abandoned Applications
239

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6890629 [patent_doc_number] => 20010007860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'METHOD OF DNA VACCINATION' [patent_app_type] => new-utility [patent_app_number] => 09/113836 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15669 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007860.pdf [firstpage_image] =>[orig_patent_app_number] => 09113836 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/113836
METHOD OF DNA VACCINATION Jul 9, 1998 Abandoned
09/112655 POLYNUCLEOTIDE VACCINE FORMULATIONS Jul 8, 1998 Abandoned
09/101226 CELLULAR IMMUNOGENS USEFUL AS CANCER VACCINES Jul 1, 1998 Abandoned
Array ( [id] => 1231675 [patent_doc_number] => 06693086 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Systemic immune activation method using nucleic acid-lipid complexes' [patent_app_type] => B1 [patent_app_number] => 09/104759 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 43 [patent_no_of_words] => 27625 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693086.pdf [firstpage_image] =>[orig_patent_app_number] => 09104759 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/104759
Systemic immune activation method using nucleic acid-lipid complexes Jun 24, 1998 Issued
Array ( [id] => 1268558 [patent_doc_number] => 06652850 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity' [patent_app_type] => B1 [patent_app_number] => 09/000003 [patent_app_country] => US [patent_app_date] => 1998-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 62 [patent_no_of_words] => 26471 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/652/06652850.pdf [firstpage_image] =>[orig_patent_app_number] => 09000003 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/000003
Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity Jun 14, 1998 Issued
Array ( [id] => 4286118 [patent_doc_number] => 06268214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Vectors encoding a modified low affinity nerve growth factor receptor' [patent_app_type] => 1 [patent_app_number] => 9/094577 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 9247 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268214.pdf [firstpage_image] =>[orig_patent_app_number] => 094577 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/094577
Vectors encoding a modified low affinity nerve growth factor receptor Jun 11, 1998 Issued
08/973602 COLORECTAL CANCER RISK FACTOR DETECTION AND TREATMENT Jun 3, 1998 Abandoned
Array ( [id] => 4103623 [patent_doc_number] => 06056952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Selective elimination of T cells that recognize specific preselected targets' [patent_app_type] => 1 [patent_app_number] => 9/029045 [patent_app_country] => US [patent_app_date] => 1998-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21396 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/056/06056952.pdf [firstpage_image] =>[orig_patent_app_number] => 029045 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/029045
Selective elimination of T cells that recognize specific preselected targets Jun 1, 1998 Issued
Array ( [id] => 4124049 [patent_doc_number] => 06127172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Materials and methods for delivery and expression of heterologous DNA in vertebrate cells' [patent_app_type] => 1 [patent_app_number] => 9/086651 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2527 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127172.pdf [firstpage_image] =>[orig_patent_app_number] => 086651 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/086651
Materials and methods for delivery and expression of heterologous DNA in vertebrate cells May 28, 1998 Issued
Array ( [id] => 544636 [patent_doc_number] => 07163925 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-16 [patent_title] => 'p16 expression constructs and their application in cancer therapy' [patent_app_type] => utility [patent_app_number] => 09/080935 [patent_app_country] => US [patent_app_date] => 1998-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 18616 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163925.pdf [firstpage_image] =>[orig_patent_app_number] => 09080935 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/080935
p16 expression constructs and their application in cancer therapy May 18, 1998 Issued
Array ( [id] => 5875376 [patent_doc_number] => 20020049404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'FAS LIGAND EXPRESSING ANTIGEN PRESENTING CELLS FOR TOLERANCE INDUCTION' [patent_app_type] => new [patent_app_number] => 09/079834 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12491 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049404.pdf [firstpage_image] =>[orig_patent_app_number] => 09079834 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/079834
FAS LIGAND EXPRESSING ANTIGEN PRESENTING CELLS FOR TOLERANCE INDUCTION May 14, 1998 Abandoned
09/078904 EXPRESSION VECTORS FOR STIMULATING AN IMMUNE RESPONSE AND METHODS OF USING SAME May 12, 1998 Abandoned
Array ( [id] => 1536385 [patent_doc_number] => 06337321 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity' [patent_app_type] => B1 [patent_app_number] => 09/075509 [patent_app_country] => US [patent_app_date] => 1998-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13828 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337321.pdf [firstpage_image] =>[orig_patent_app_number] => 09075509 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/075509
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity May 7, 1998 Issued
Array ( [id] => 4295552 [patent_doc_number] => 06235968 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Metastasis models using green fluorescent protein (GFP) as a marker' [patent_app_type] => 1 [patent_app_number] => 9/067734 [patent_app_country] => US [patent_app_date] => 1998-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6199 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235968.pdf [firstpage_image] =>[orig_patent_app_number] => 067734 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/067734
Metastasis models using green fluorescent protein (GFP) as a marker Apr 27, 1998 Issued
Array ( [id] => 7636981 [patent_doc_number] => 06379674 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Use of herpes vectors for tumor therapy' [patent_app_type] => B1 [patent_app_number] => 09/064174 [patent_app_country] => US [patent_app_date] => 1998-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 9491 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379674.pdf [firstpage_image] =>[orig_patent_app_number] => 09064174 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/064174
Use of herpes vectors for tumor therapy Apr 21, 1998 Issued
Array ( [id] => 1602746 [patent_doc_number] => 06432925 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'RNA cancer vaccine and methods for its use' [patent_app_type] => B1 [patent_app_number] => 09/061794 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8608 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432925.pdf [firstpage_image] =>[orig_patent_app_number] => 09061794 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/061794
RNA cancer vaccine and methods for its use Apr 15, 1998 Issued
Array ( [id] => 4364047 [patent_doc_number] => 06255555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Transgenic mouse expressing human fusin and human CD4' [patent_app_type] => 1 [patent_app_number] => 9/061048 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6095 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255555.pdf [firstpage_image] =>[orig_patent_app_number] => 061048 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/061048
Transgenic mouse expressing human fusin and human CD4 Apr 15, 1998 Issued
Array ( [id] => 4348263 [patent_doc_number] => 06284879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Transport associated protein splice variants' [patent_app_type] => 1 [patent_app_number] => 9/061764 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 18626 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284879.pdf [firstpage_image] =>[orig_patent_app_number] => 061764 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/061764
Transport associated protein splice variants Apr 15, 1998 Issued
Array ( [id] => 4237300 [patent_doc_number] => 06080576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Vectors for gene trapping and gene activation' [patent_app_type] => 1 [patent_app_number] => 9/057328 [patent_app_country] => US [patent_app_date] => 1998-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 17830 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080576.pdf [firstpage_image] =>[orig_patent_app_number] => 057328 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/057328
Vectors for gene trapping and gene activation Apr 7, 1998 Issued
Array ( [id] => 4295539 [patent_doc_number] => 06235967 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Metastasis models using green fluorescent protein as a marker' [patent_app_type] => 1 [patent_app_number] => 9/049544 [patent_app_country] => US [patent_app_date] => 1998-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5084 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235967.pdf [firstpage_image] =>[orig_patent_app_number] => 049544 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/049544
Metastasis models using green fluorescent protein as a marker Mar 26, 1998 Issued
Menu